Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia

Journal of Neuroscience

Volumn 22, Issue 13, 2002, Pages 5334-5343

  Repovic, Pavle ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Astrocytes; cAMP; Macrophage; Microglia; Oncostatin M; Prostaglandin E2

Indexed keywords

2',5' DIDEOXYADENOSINE; ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP DERIVATIVE; FORSKOLIN; INDOMETACIN; INTERLEUKIN 1BETA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; ONCOSTATIN M; PROSTAGLANDIN E2; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; INTERLEUKIN 1; MESSENGER RNA; OSM PROTEIN, HUMAN; OSM PROTEIN, MOUSE; PEPTIDE;

ARTICLE; ASTROCYTE; CELL INTERACTION; CELL LINE; COCULTURE; HUMAN; HUMAN CELL; MACROPHAGE; MICROGLIA; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; MUTATION; PROMOTER REGION; TRANSACTIVATION;

ANIMALS; ASTROCYTES; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-1; MACROPHAGES; MICE; MICROGLIA; MONOCYTES; MUTATION; ONCOSTATIN M; PEPTIDES; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0036628540     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-13-05334.2002     Document Type: Article

References (70)

1. Ahn CS, Athans JC, Rosenberg IN (1969) Stimulation of thyroid hormone secretion by dibutyryl cyclic-AMP. Endocrinology 85:224-230.
2. Andjelkovic AV, Kerkovich D, Pachter JS (2000) Monocyte: Astrocyte interactions regulate MCP-1 expression in both cell types. J Leukoc Biol 68:545-552.
3. Asboth G, Phaneuf S, Eure-Finner GN, Toth M, Bernal AL (1996) Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: Involvement of EP1 and EP3 receptor subtypes. Endocrinology 137:2572-2579.
4. Barillari G, Albonici L, Incerpi S, Bogetto L, Pistritto G, Volpi A, Ensoli B, Manzari V (2001) Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing α5/β1 integrin expression and function. Atherosclerosis 154:377-385.
5. Baumann H, Wang Y, Richards CD, Jones CA, Black TA, Gross KW (2000) Endotoxin-induced renal inflammatory response. J Biol Chem 275:22014-22019.
6. 2. Brain Res 777:210-218.
7. Brosnan CF, Raine CS (1996) Mechanisms of immune injury in multiple sclerosis. Brain Pathol 6:243-257.
8. Brown TJ, Lioubin MN, Marquardt H (1987) Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. J Immunol 139:2977-2983.
9. Caggiano AO, Kraig RP (1999) Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-lbeta production. J Neurochem 72:565-575.
10. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K. Toshioka T, Hidaka H (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma. J Biol Chem 265:5267-5272.
11. Clegg CH, Correll LA, Cadd GG, McKnight GS (1987) Inhibition of intracellular cAMP-dependent protein kinase using mutant genes of the regulatory type I subunit. J Biol Chem 262:13111-13119.
12. Crichton MB, Nichols JE, Zhao Y, Bulun SE, Simpson ER (1996) Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol Cell Endocrinol 118:215-220.
13. Ensoli F, Fiorelli V, DeCristofaro M, Muratori DS, Novi A, Vannelli B, Thiele CJ, Luzi G, Aiuti F (1999) Inflammatory cytokines and HIV-1 associated neurodegeneration: Oncostatin-M produced by mononuclear cells from HIV-1 infected individuals induces apoptosis of primary neurons. J Immunol 162:6268-6277.
14. Fedyk ER, Phipps RP (1996) Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci USA 93:10978-10983.
15. Fiala M, Rhodes RH, Shapshak P, Nagano I, Martinez-Maza O, Diagne A, Baldwin G, Graves M (1996) Regulation of HIV-1 infection in astrocytes: Expression of Nef, TNF-α and IL-6 is enhanced in coculture of astrocytes with macrophages. J Neurovirol 2:158-166.
16. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein LB, Gendelman HE (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J Exp Med 176:1703-1718.
17. Gill DM, Meren R (1978) ADP-ribosylation of membrane proteins catalyzed by cholera toxin: Basis of the activation of adenylate cyclase. Proc Natl Acad Sci USA 75:3050-3054.
18. Grenier A, Dehoux M, Boutten A, Arce-Vicioso M, Durand G, Gougerot-Pocidalo M-A, Chollet-Martin S (1999) Oncostain M production and regulation by human polymorphonuclear neutrophils. Blood 93:1413-1421.
19. Guerrero JM, Prieto JC, Calvo JR, Goberna R (1984) Activation of cyclic AMP-dependent protein kinase by VIP in blood mononuclear cells. Peptides 5:371-373.
20. Hartung HP, Schäfer B, Heininger K, Toyka K (1989) Tumor necrosis factor α enhances generation and release of arachidonic acid-derived inflammatory and immunoregulatory mediators by astrocytes. Neurology 39:386.
21. Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1998) Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. J Rheumatol 25:308-313.
22. Janabi N, Hau I, Tardieu M (1999) Negative feedback between prostaglandin and α- and β-chemokine synthesis in human microglial cells and astrocytes. J Immunol 162:1701-1706.
23. Katsuura G, Gottschall PE, Dahl RR, Arimura A (1989) Interleukin-1 beta increases prostaglandin E2 in rat astrocyte cultures: Modulatory effect of neuropeptides. Endocrinology 124:3125-3127.
24. Knight BL, Fordham RA (1975) The separation, properties and possible subunit composition of adenosine 3′, 5′-monophosphate-dependent protein kinases in brown adipose tissue. Biochim Biophys Acta 384:102-111.
25. Komorowski J, Gradowski G, Stepien H (1997) Effects of human chorionic gonadotropin (hCG) and β-hCG on oncostatin M release from human peripheral blood mononuclear cells in vitro. Cytobios 92:159-163.
26. 1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem 273:4112-4118.
27. Lee TH, Linstedt AD (2000) Potential role for protein kinases in regulation of bidirectional endoplasmic reticulum-to-Golgi transport revealed by protein kinase inhibitor H89. Mol Biol Cell 11:2577-2590.
28. Lee Y-J, Han Y, Lu H-T, Nguyen V, Qin H, Howe PH, Hocevar BA, Boss JM, Ransohoff RM, Benveniste EN (1997) TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II trans-activator messenger RNA expression. J Immunol 158:2065-2075.
29. Levi G, Minghetti L, Aloisi F (1998) Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie 80:899-904.
30. Levy MT, Trojanowska M, Reuben A (2000) Oncostatin M: A cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells. J Hepatol 32:218-226.
31. Ling E-A (1981) The origin and nature of microglia. In: Advances in Cellular Neurobiology (Federoff S, Hertz L, eds), pp 33-82. New York: Academic.
32. Ma Y, Streiff RJ, Liu J, Spence MJ, Vestal RE (1999) Cloning and characterization of human oncostatin M promoter. Nucleic Acids Res 27:4649-4657.
33. Malik N, Kallestad JC, Gunderson NL, Austin SD, Neubauer MG, Ochs V, Marquardt H, Zarling JM, Shoyab M, Wei C-M, Linsley PS, Rose TM (1989) Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol 9:2847-2853.
34. Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ (2000) Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 43:281-288.
35. Mitsuhashi M, Ohashi Y, Shichijo S, Christian C, Sudduth-Klinger J, Harrowe G, Payan DG (1992) Multiple intracellular signaling pathways of the neuropeptide substance P receptor. J Neurosci Res 32:437-443.
36. Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA, McIntyre TM (1997) Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 100:158-168.
37. Molina-Holgado E, Ortiz S, Molina-Holgado F, Guaza C (2000) Induction of COX-2 and PGE(2) biosynthesis by IL-1β is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br J Pharmacol 131:152-159.
38. Montminy M (1997) Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66:807-822.
39. Montminy MR, Bilezikjian LM (1987) Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328:175-178.
40. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S (1993) Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365:166-170.
41. Narumiya S, FitzGerald GA (2001) Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108:25-30.
42. Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: Structures, properties, and functions. Physiol Rev 79:1193-1226.
43. Nguyen VT, Benveniste EN (2000) Involvement of STAT-1α and ets family members in interferon-γ induction of CD40 transcription in macrophages/microglia. J Biol Chem 271:23674-23684.
44. Nogawa S, Zhang F, Ross ME, Iadecola C (1997) Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17:2746-2755.
45. Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z (1997) The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum 40:1096-1105.
46. Pahan K, Sheikh FG, Liu X, Hilger S, McKinney M, Petro TM (2001) Induction of nitric-oxide synthase and activation of NF-κ B by interleukin-12 p40 in microglial cells. J Biol Chem 276:7899-7905.
47. Patrizio M, Colucci M, Levi G (2000) Protein kinase C activation reduces microglial cyclic AMP response to prostaglandin E2 by interfering with EP2 receptors. J Neurochem 74:400-405.
48. Pereira CF, Middel J, Jansen G, Verhoef J, Nottet HS (2001) Enhanced expression of fractalkine in HIV-1 associated dementia. J Neuroimmunol 115:168-175.
49. Pistritto G, Franzese O, Pozzoli G, Mancuso C, Tringali G, Preziosi P, Navarra P (1999) Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclo-oxygenase: Evidence for the involvement of nuclear factor κB. Biochem Biophys Res Commun 263:570-574.
50. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and Matlnspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-4884.
51. Radka SF, Nakamura S, Sakurada S, Salahuddin SZ (1993) Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma. J Immunol 150:5195-5201.
52. Rettori V, Gimeno M, Lyson K, McCann SM (1992) Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus. Proc Natl Acad Sci USA 89:11543-11546.
53. Rozic JG, Chakraborty C, Lala PK (2001) Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer 93:497-506.
54. Ruprecht K, Kuhlmann T, Seif F, Hummel V, Kruse N, Bruck W, Rieckmann P (2001) Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J Neuropathol Exp Neurol 60:1087-1098.
55. Seamon KB, Padgett W, Daly JW (1981) Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA 78:3363-3367.
56. Shayo C, Davio C, Brodsky A, Mladovan AG, Legnazzi BL, Rivera E, Baldi A (1997) Histamine modulates the expression of c-fos through cyclic AMP production via the H2 receptor in the human promonocytic cell line U937. Mol Pharmacol 51:983-990.
57. Sodhi A, Shishodia S, Shrivastava A (1997) Cisplatin-stimulated murine bone marrow-derived macrophages secrete oncostatin M. Immunol Cell Biol 75:492-496.
58. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT (2000) COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89:2637-2645.
59. Van Wagoner NJ, Benveniste EN (1999) Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 100:124-139.
60. Van Wagoner NJ, Choi C, Repovic P, Benveniste EN (2000) Oncostatin M regulation of interleukin-6 expression in astrocytes: Biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J Neurochem 75:563-575.
61. Vasse M, Pourtau J, Trochon V, Muraine M, Vannier J-P, Lu H, Soria J, Soria C (1999) Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 19:1835-1842.
62. Vegeto E, Bonincontro C, Pollio G, Sala A. Viappiani S, Nardi F, Brusadelli A, Viviani B, Ciana P, Maggi A (2001) Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 21:1809-1818.
63. Vos JP, Gard AL, Pfeiffer SE (1996) Regulation of oligodendrocyte cell survival and differentiation by ciliary neurotrophic factor, leukemia inhibitory factor, oncostatin M, and interleukin-6. Perspect Dev Neurobiol 4:39-52.
64. Wahl AF, Wallace PM (2001) Oncostatin M in the anti-inflammatory response. Ann Rheum Dis 60:iii75-iii80.
65. Wallace PM, MacMaster JF, Rouleau KA, Brown TJ, Loy JK, Donaldson KL, Wahl AF (1999) Regulation of inflammatory responses by oncostatin M. J Immunol 162:5547-5555.
66. Yamagata K, Matsumura K, Inoue W, Shiraki T, Suzuki K, Yasuda S, Sugiura H, Cao C, Watanabe Y, Kobayashi S (2001) Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 21:2669-2677.
67. Yanagisawa M, Nakashima K, Taga T (1999) STAT3-mediated astrocyte differentiation from mouse fetal neuroepithelial cells by mouse oncostatin M. Neurosci Lett 269:169-172.
68. Yoshimura A, Ichihara M, Kinjyo I, Moriyama M, Copeland NG, Gilbert DJ, Jenkins NA, Hara T, Miyajima A (1996) Mouse oncostatin M: An immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J 15:1055-1063.
69. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ (1986) Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 83:9739-9743.
70. Zenser TV, Wannemacher RW Jr (1976) Inhibition of cholera toxinstimulated intestinal epithelial cell adenylate cyclase by adenosine analogs. Proc Soc Exp Biol Med 152:126-129.